The advanced wound dressing market size was valued at USD 8.3 billion in 2023, driven by the emphasis on treating chronic wounds occurring due to diabetes, obesity, and age across the globe. The market is expected to grow at a CAGR of 4.3% during the forecast period of 2024-2032, with the values likely to rise from USD 8.7 billion in 2024 to USD 12.2 billion by 2032.
Skin is the body’s largest organ and plays a vital role for the body such as maintaining a physical barrier and temperature regulation. People suffer from different types of skin damage or burns by accidents or flames, which leads to a skin wound. A wound can be described as a discontinuity of the skin epithelial or mucosa, caused by thermal or physical damage. They can be present at any part of the body.
The wound healing process consists of three basic phases: inflammation, proliferation, and maturation. With different types of wounds, and different medical advances, skin lesions are treated with various products. The overall motive of wound dressing is to reduce pain, protect the environment from pathogens, external solids and wastes and apply compression for hemostasis.
Acute and chronic wounds affect more than 6 million people in the United States alone. Despite the presence of significant technologies in wound care, drug resistance and biofilm colonization are some of the major challenges faced in wound management. As a result, the advanced wound dressing market demand has grown during the historical period.
As wound dressing is a breeding place for microorganisms, new materials like fucoidan, sponges, hydrocolloids, hydrofibers, collagen, hydrogels and films are being used in the market. Antimicrobial wound dressings that release antiseptics to kill the microorganisms may contain either silver (Aquacel AG), nano-crystalline silver (ACTICOAT) or cadexomer iodine (Iodosorb™). To prevent the wound from gram positive and negative bacteria, scientists have developed a cotton roving fabric with 0.5% chlorhexidine acetate called Bactigras™.
A wireless sensor inbuilt smart bandage has also been introduced in the market, focused on treating chronic wounds. It uses electrical stimulation and biosensors to facilitate wound healing and decrease scar formation by increasing blood flow to the injured tissue.
In June 2024, JeNaCell, a part of Evonik, also launched a moist wound dressing called Epicite® for chronic wound treatment. This wound dressing can be used to heal diabetic foot ulcers, venous or arterial leg ulcers, pressure ulcers and soft tissue lesions. With the ongoing developments, the advanced wound dressing market growth is certain in the future.
Market Breakup by Products
Market Breakup by Applications
Market Breakup by End User
Market Breakup by Region
Most of the advanced wound dressing market share was dominated by North America during the historic period. The presence of key healthcare players is a major factor for a huge market. For instance, Convatec Group Plc has acquired a new anti-invective nitric oxide technology from 30 Technology Limited to expand its research and development in advanced wound care. The LifeNet Health acquisition of Bioventus can also bring some major development in the market.
Nonetheless, the European market is also bringing some innovative developments to the market. Researchers from Sweden have developed nanocellulose made wound dressing to reveal early detection of infection in the wound with disrupting the wound healing process.
Moreover, Coloplast, a Danish company, has also acquired a Kerecis, an Iceland based biologic wound care for USD 1.3 billion. This firm utilizes fish skin to develop tissue-transplant products. Hence, we can assume the European market will grow as well.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Products||
|Breakup by Applications||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Advanced Wound Dressing Market Overview
3.1 Global Advanced Wound Dressing Market Historical Value (2017-2023)
3.2 Global Advanced Wound Dressing Market Forecast Value (2024-2032)
4 Global Advanced Wound Dressing Market Landscape
4.1 Advanced Wound Dressing: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Advanced Wound Dressing: Product Landscape
4.2.1 Analysis by Products
4.2.2 Analysis by Applications
5 Global Advanced Wound Dressing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Advanced Wound Dressing Market Segmentation
6.1 Global Advanced Wound Dressing Market by Products
6.1.1 Market Overview
6.1.2 Infection Management
6.1.3 Exudate Management
6.1.4 Active Wound Care
6.1.5 Therapy Devices
6.2 Global Advanced Wound Dressing Market by Applications
6.2.1 Market Overview
6.2.2 Chronic Wounds
6.2.3 Acute Wounds
6.3 Global Advanced Wound Dressing Market by End User
6.3.1 Market Overview
6.3.3 Community Health Service Centres
6.4 Global Advanced Wound Dressing Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Advanced Wound Dressing Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Advanced Wound Dressing Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Advanced Wound Dressing Market
9.1 Market Share by Country
10 Latin America Advanced Wound Dressing Market
10.1 Market Share by Country
11 Middle East and Africa Advanced Wound Dressing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 3M (Acelity Inc.)
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Adynxx, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 B Braun Melsungen AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 ConvaTec Group plc
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Essity AB (BSN Medical GmbH)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Integra Lifesciences (Derma sciences)
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Investor AB (Mölnlycke Health Care AB)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Johnson & Johnson
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Medline Industries, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Medtronic plc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 8.3 billion in 2023, driven by the focus on preventing infections and prolonged healing in chronic wounds globally.
The market is anticipated to grow at a CAGR of 4.3% during the forecast period of 2024-2032, likely to reach a market value of USD 12.2 billion by 2032.
Chronic wounds mostly show delayed healing, attributed to aging, diabetes, or medication compliance. With the incidence of diabetes and an aging population globally, the market demand for advanced wound dressing has increased as well.
New dressing materials that inhibit microbial proliferation around the wound have emerged in the market. It may contain either silver (Aquacel AG), nano-crystalline silver (ACTICOAT) or cadexomer iodine (Iodosorb™). Mergers and acquisitions among market leaders is also a trend set to bring new innovations in the market.
It includes infection management, exudate management, active wound care, and therapy devices.
Advanced wound dressing is applicable in chronic as well as acute wounds.
End users include hospitals and community health service centres.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are 3M (Acelity Inc.), Adynxx, Inc., B Braun Melsungen AG, ConvaTec Group plc, Essity AB (BSN Medical GmbH), Integra Lifesciences (Derma sciences), Investor AB (Mölnlycke Health Care AB), Johnson & Johnson, Medline Industries, Inc., and Medtronic plc.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.